1[1] Horoszewicz JS,et al.Monoclonal antibodies to a new antigenic marker In epithelial prostatic cells and serum of prostatic cancer patients [J].Anticancer Res,1987,7∶927-936.
2[2] Israeli RS,et al.Expression of the prostate-specific membrane antigen[J].Cancer Res,1994,54∶1807-1811.
3[3] Troyer JK,et al.Detection and characterization of the prostate -specific membrane antigen(PSMA)in tissue extracts and body fluids[J] .Int J Cancer,1995,62∶552-558.
4[4] Leek J,et al.Prostate-specific membrane antigen:evidence f or the existence of a second related human gene[J].Br J Cancer, 1995,72∶583-588.
5[5] Rinker schaeffer CW,et al.Localization and physical mapping of the prostate-specific membrane antigen(PSM)gene to human chromosome 11.Gen omics,1995,30∶105-108.
6[6] Israeli RS,et al.Molecular cloning of a complementary DNA en coding a prostate-specific membrane antigen[J].Cancer Res,1993,53∶227-230 .
7[7] Von Heijne G.Transending the impenetrable:how proteins come to ter ms with membranes[J].Biochim Biophys Acta,1988,947∶307-333.
8[8] Parks GD,et al.Topology of eukaryotic type Ⅱ membrane prote ins:importance of N-terminal positively charged resigues flanking the h ydrophobic domain.Cell,1991,64∶777-787.
9[9] Kawakami M,et al.Enhanced expression of prostate-specific m embrane antigen gene in prostate cancer as revealed by in situ hybridization [J].Cancer Res,1997,57∶2321-2324.
10[10] Carter RE,et al.Prostate-specific membrane antigen is a hydr olase with substrate and pharmacologic characteristics of a neuropeptidase[J]. Proc Natl Acad Sci USA,1996,93∶749-753.
2[1]Adam B L,Qu Y,Davis J W,et al.Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and health men[J].Cancer Res,2002,62 (13):3609-3614.
3[2]Xiao Z,Adam B L,Cazares L H,et al.Quantitation of serum prostatespecific membrane antigen by a novel protein biochip immunoassay discriminates benign from malignant prostate diseases[J].Cancer Res,2001,61 (16):6029-6033.
4[6]Alaiya A A,Franzn B,Auer G,et al.Cancer proteomics:from identification of novel marker to creation of artificial leaning models fortumor classification[J].Electrophoresis,2000,21 (6):1210-1217.
5[7]Ahmed M I,Abd-Elmotelib F,Farag R M,et al.Evaluation of some tissue and serum biomarkers in prostatic carcinoma among E-gyptian males[J].Clin Biochem,1999,32(6):439-445.
6[8]Cheng L,Lloyd R V,Veavear L,et al.The cell cycle inhibitors p27 WAF1 and p27 KIPI are associated with survival in patients treated by salvage prostatectomy after radiation therapy[J].Clin Cancer Res,2000,6(5):1896-1899.
7[9]Kim M J,Bhatia Gaur R,Banach Petrosky W A,et al.NKX3.1 mutant mice recapitulate early stages of prostate carcinogenesis[J].Cancer Res,2002,62 (11):2999-3004.
8[10]Gao A C,Lou W,Isaacs J T.Down-regulation of homeobox gene GBX2 expression inhibits human prostate cancer clonogenic ability and tumorigenicity[J].Cancer Res,1998,58 (7):1391-1394.
9[11]Asmann Y W,Kosari F,Wang K,et al.Identification of differentially expressed genes in normal and malignant prostate by electronic profiling of expressed sequence tags[J].Cancer Res,2002,62 (11):3308-3314.
10[12]Waghray A,Schober M,Feroze F,et al.Identification of differentially expressed genes by seral analysis of expression in human prostate cancer[J].Cancer Res,2001,61 (10):4283-4286.
